Lexology January 23, 2025
BRG

THREE IN TEN ASSUME CONTINUED CHOPPINESS IN EARLY 2025, THEN 85% PROJECT MORE DEALS Investment in healthcare is expected to pick up in 2025, likely midyear, even amid some uncertainty with changes in the federal government. Competition will be significant as nearly three-quarters of the 127 investors plan to focus on three of the most promising sectors: (1) infusion pharmacy, buoyed by a robust pipeline with 60% of the drugs in IV form; (2) behavioral health, which has become a must-have for portfolios given the ongoing mental health crisis; and (3) services focused on care in the home, principally paid by government, and driven by either tech or staffing, or both. Despite these compelling opportunities, for the first time in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Trends
How the Longevity Economy is creating a generational opportunity for investors
Lindus Health completes $55m funding round
The Ups and Downs of AI for Pharma Investors
TailorMed Secures $40 Million to Expand the Largest Affordability Network into an End-to-End Platform, Transforming Patient Access to Care Nationwide
BridgeBio’s Neil Kumar on an underdog drug launch and wooing deal-hungry investors

Share This Article